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Background: We sought to validate total atrial conduction time (TACT) measurement via tissue Doppler
imaging (TDI) by comparing the electrophysiological study (EPS) measurements of healthy subjects,
according to age and sex.
Methods: Eighty patients with normal EPS results were included. TACT was measured by EPS and TDI. For
validation, the results of TDI were compared with those of EPS. TACT was assessed by measuring the time
interval between the beginning of the P-wave on the surface ECG, and the peak A-wave on TDI from the
left atrial lateral wall, just over the mitral annulus. Electrophysiological TACT was deﬁned as the time
from the high right atrial electrogram to the distal coronary sinus atrial electrogram around the left
lateral portion of the mitral ring.
Results: EPS and TDI measurements of the TACT were signiﬁcantly and positively correlated among men
and women in 20–30 years (p¼0.008, r¼0.412; p40.001, r¼0.706, respectively), and those in the 30–40
years group (p¼0.001, r¼0.649; p¼0.001, r¼0.696). In contrast, EPS and TDI measurements of TACT
were not signiﬁcantly different among men and women in the 20–30 years and those in the 30–40 years
group (p40.05, for both). On univariate regression analyses, TACT was independently associated with
age (β¼0.342, ¼0.001).
Conclusions: When assessed according to the age and sex of healthy participants, TDI and EPS measure-
ments during TACT assessments were similar and correlated with each other. The measurement of TACT via
TDI may be used accurately and conﬁdently than the measurement via EPS in healthy individuals.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prolongation of total atrial conduction time (TACT) has been
shown to increase the risk of atrial ﬁbrillation in many studies [1–
3]. Many different methods can be used to evaluate the TACT.
Although 12-lead, signal-averaged, M-mode, and tissue Doppler
echocardiography are usually used, intracardiac measurements
using the electrophysiological study (EPS) remain the gold stan-
dard method. In recent years, 2-dimensional echocardiographic
tissue Doppler has been used for measuring the ACT (atrial con-
duction time) in many clinical studies. Although it is not the gold
standard, this non-invasive method is usually preferred for ACT
measurements [1,2,4]. However, to the best of our knowledge, no
study has directly compared the TDI TACT measurements with theblished by Elsevier B.V. This is an
; fax: þ90 3742534615.
m).currently accepted gold standard electrophysiological TACT mea-
surements for validation, except one where conventional Doppler
echocardiography was used instead of TDI in healthy subject [5].
Moreover, no validation study has been performed among differ-
ent age and sex groups in subjects with normal EPS results. In this
study, we aimed to compare the TACT measured by TDI and EPS
according to age and sex among healthy individuals without car-
diovascular and systemic diseases for the purpose of validation of
TDI use in the evaluation of TACT.2. Methods
2.1. Study population
Eighty healthy subjects with normal EPS results (40 women
and 40 men; 2 different age groups [20–30 and 30–40 years]), who
were referred to our EPS laboratory for various reasons, such asopen access article under the CC BY-NC-ND license
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Four groups, consisting of 20 subjects in each group, were orga-
nized according to age and gender (Group A: women, aged 20–30;
Group B: women, aged 30–40; Group C: men, aged 20–30; Group
D: men, aged 30–40). Only individuals with normal EPS results
were included. Subjects with any kind of known systemic disease
and history of drug use that may affect the conduction system
were excluded. All subjects had normal cardiac anatomy, cardiac
systolic and diastolic functions on echocardiography, and normal
sinus rhythm on electrocardiography (ECG). The entire study
population's demographic characteristics, biochemical parameters,
lipid values, and ECGs were obtained. Patients with at least one of
the following conditions were excluded from the study: hyper-
thyroidism, hypothyroidism, acute coronary syndrome, prior
myocardial infarction and coronary artery disease, congestive
heart failure, left ventricular (LV) hypertrophy, left and right atrial
enlargement, prolonged QRS duration (Z120 msn), reduced LV
ejection fraction (o55%), atrial ﬂutter or ﬁbrillation, signiﬁcant
valvular heart disease, pacemaker implantation, frequent ven-
tricular pre-excitation and atrio-ventricular conduction abnorm-
alities, diabetes mellitus, arterial hypertension (resting blood
pressure Z140/90 or antihypertensive drug use), medications
known to alter cardiac conduction, peripheral vascular diseases,
congenital heart disease, pulmonary or neurological disease,
pericarditis, peripheral neuropathy, alcohol abuse, renal or hepatic
disease and poor echocardiographic imaging. Echocardiographic
measurements were obtained after the completion of electro-
physiological studies in the same day. The local ethics committee
approved this study and all subjects gave their informed consent
prior to participation.
2.2. Conventional echocardiography
All subjects were evaluated by transthoracic M mode, two
dimensional (2D), pulsed-wave (PW), continuous wave (CW), color
ﬂow, and tissue Doppler imaging (TDI). Echocardiographic exam-
inations were performed using the GE- Vivid-3 system (GE
Vingmed, Horten, Norway) with a 2–4 MHz transducer at a depth
of 16 cm. During echocardiography, continuous single-lead ECG
recording was obtained. Images were obtained in the left lateral
decubitus position. The 2D and conventional Doppler examina-
tions were obtained in the parasternal and apical views, according
to the guidelines of the American Society of Echocardiography [6].
LV diameters and wall thickness were measured by M-mode
echocardiography. LV ejection fraction was calculated using the
apical two-and four-chamber views by Simpson's method,
according to American Society of Echocardiography guidelines [6].
The mitral valve inﬂow patterns [E-wave, A-wave, E-wave decel-
eration time (Dt), E/A ratios, and isovolumic relaxation times
(IVRT)] were measured using PW Doppler.
2.3. Tissue Doppler echocardiography
TDI was performed using transducer frequencies of 3.5–4.0 MHz,
adjusting the spectral pulsed Doppler signal ﬁlters until the Nyquist
limit of 15–20 cm/s was reached, and using the minimal optimal
gain. Myocardial TDI velocities (Peak systolic [Sm], early diastolic
[Em] and late diastolic velocities [Am]) were measured via spectral
pulsed Doppler of the LV-free wall from the apical four-chamber
view [6]. The ultrasound beam was positioned, as parallel as possi-
ble, to the myocardial segment in order to acquire the optimal
imaging angle. A novel echocardiographic consideration based on
TDI was introduced in order to assess the total atrial conduction
time [4]. The total atrial conduction time was assessed by measuring
the time interval between the beginning of the P wave on the sur-
face ECG and the point of the peak Awave on TDI from the LA lateralwall just over the mitral annulus [2,4]. All measurements were
repeated three times and average values were received for each of
the parameters. The measurements were also corrected for the heart
rate using the following formula: Corrected ACT¼ACT800/R-R
[5,7]. Two experienced investigators, who were unaware of the
subject's clinical status, performed all measurements. If a difference
of 45% in any of the variables measured by both investigators was
found, the patient was not included, whereas if the difference was
o5%, the measurements were averaged.
2.4. Electrophysiology study
All patients underwent an EPS after at least 6–8 h fasting. The
measurements related to the ACT were performed on subjects
with normal EPS results using four multi-electrode mapping
catheters (Medtronic, Inc., USA). Intracardiac recordings were
received via a computer with EP Tracer (CardioTek, Maastricht, the
Netherlands) software. Surface ECG and intracardiac electrograms
(EGMs) were recorded simultaneously, and the conduction times
were measured at a rate of 300 mm/s. The ﬁrst quadripolar
catheter was placed on the high right atrial (HRA) region. A second
decapolar catheter was positioned into the coronary sinus (CS)
around the left lateral portion of the mitral ring. Additionally,
another catheter was placed on the His bundle (HB) region. Elec-
trophysiological total atrial conduction time was deﬁned as the
time from the atrial HRA electrogram to the distal CS atrial elec-
trogram around the left lateral portion of the mitral ring. The
measurements were also corrected for the heart rate as the TDI
measurements using the mentioned formula [5,7].3. Statistical analysis
All analyses were performed using the SPSS (SPSS Inc., Chicago,
IL, USA) software package. All data were presented as the
mean7standard deviation. Total atrial conduction time measure-
ments by the two methods were compared using the paired t tests.
The comparison of echocardiographic data between the two groups
were performed using one-way analysis of variance (ANOVA) with
post hoc analysis by Tukey's Honestly Signiﬁcant Difference (HSD)
or independent sample t-tests, and Kruskal–Wallis tests or Mann–
Whitney U test for normally and abnormally distributed data,
respectively. Correlations between variables were tested by means
of Pearson's bivariate correlation testing. We used a univariate
logistic regression analysis to quantify the association of variables
with TACT. Variables that were found to be statistically signiﬁcant in
the univariate analysis and other potential confounders were used
in a multiple logistic regression model using the forward stepwise
method, in order to determine the independent prognostic factors.
Analyses of the differences in the TDI and EPS measurements were
performed according to the Bland–Altman technique. A value of
po0.05 was considered statistically signiﬁcant.4. Results
4.1. Clinical and echocardiographic assessment
The clinical cardiovascular examination, chest radiography,
cardiac systolic and diastolic functions, cardiac volumes, and
ejection fractions were normal in all subjects. Baseline demo-
graphic and laboratory characteristics of all subjects are shown in
Table 1. Additionally, the echocardiographic characteristics of all
subjects are shown in Table 2. There were no complications related
to the EPS procedures.
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Measurements were recorded successfully in all subjects. The EPS
and TDI measurements of TACT were similar in male and female
subjects (68.474.4 vs. 68.674.6 ms, p40.05 and 71.474.9 vs.
71.575.3 ms, p40.05, respectively) in the 20–30 years group.
Additionally, the TACT measurements using both methods were
similar among male and female subjects (78.777.4 vs. 77.977.1 ms,
p40.05 and 77.377.3 vs. 76.977.1 ms, p40.05, respectively) in the
30–40 years group. The results of the EPS and TDI measurements of
TACT in all groups are shown in Table 3. The EPS and TDI measure-
ments of TACT were signiﬁcantly and positively correlated in male
and female subjects (p¼0.008, r¼0.412; po0.001, r¼706, respec-
tively) in the 20–30 years group. Additionally, TACT measurements
using both methods were signiﬁcantly and positively correlated
among male and female subjects (p¼0.001, r¼0.649; p¼0.001,
r¼0.696; Fig. 1) in the 30–40 years group.
The measurement score of TACT with EPS and TDI among female
subjects aged 20–30 were statistically borderline, and signiﬁcantly
lower compared to females subjects aged 30–40 (p¼0.045). How-
ever no signiﬁcantly statistical differences were found between the
two different male age groups (p¼0.098).
In all of groups, TACT with TDI was longer than TACT with EPS
(mean TACT) (1.8970.54 ms). In the subgroup analyses, TACT with
TDI was longer than TACT with EPS for all groups. However, sta-
tistically non-signiﬁcant results were observed between certain
groups (20–30 years old, males: 2.0970.31 vs. females: 1.9470.21;
30–40 years old, males: 0.3170.04, females: 0.2870.07; p40.05).
There was a positive and signiﬁcant correlation between mean TACTTable 1
Comparison of the patient characteristics according to age and sex groups.
Group I
(Women,
20–30 years)
Group II
(Men, 20–30
years)
Group III
(Women, 30–
40 years)
Group IV
(Men, 30–40
years)
Age 24.072.3 24.972.9 33.872.4 36.273.5
BMI 24.872.1 24.172.3 25.372.9 25.572.9
Heart rate 87.579.4 86.679.7 84.678.1 79.679.1
SBP, mmHg 115.1710.1 116.3710.9 118.1710.8 119.3711.4
DBP, mmHg 66.578.1 67.376.5 68.178.5 69.377.8
Glucose, mg/dL 84.877.1 83.776.9 85.477.2 84.777.9
Creatinine, mg/
dL
0.7270.14 0.7970.13 0.7370.13 0.8170.15
Total choles-
terol, mg/dL
165.1736.4 162.2734.9 170.1738.2 169.3738.7
LDL, mg/dL 101.1728.6 102.3727.8 103.4729.9 104.1730.4
HDL, mg/dL 45.2710.4 38.3711.0 45.179.7 39.1710.2
Triglyceride,
mg/dL
135.1748.1 138.9741.9 136.9749.2 137.1742.0
Hemoglobin,
mg/dL
12.971.4 13.871.8 12.271.2 13.771.7
BMI¼body mass index; DBP¼diastolic blood pressure; HDL¼high density lipo-
protein; LDL¼ low density lipoprotein; SBP¼systolic blood pressure; values are
mean7SD.
Table 2
Comparison of the echocardiographic characteristics according to age and sex groups.
Group I (Women, 20–30 years) Group II (Men, 20–30 year
EF (%) 64.075.3 64.977.9
LA diameter (mm) 31.170.9 32.371.4
RA diameter (mm) 21.573.4 20.273.7
LVED diameter (mm) 44.572.1 45.671.5
LVES diameter (mm) 28.572.3 28.771.3
LV FS (%) 37.172.5 38.273.1
EF¼ejection fraction, LA¼ left atrium, RA¼right atrium, LVED¼ left ventricular end-di
mean7SD.and TACT with EPS (r¼0.321, p¼0.041). Additionally, statistically
signiﬁcant positive correlations were observed between mean TACT
and age. However, statistically non-signiﬁcant correlations were
observed between mean TACT and sex groups (r¼0.521, p¼0.002;
r¼0.131, r¼0.216; respectively).
Among all the factors included in the univariate analyses (i.e.,
sex, age, systolic blood pressure, diastolic blood pressure, heart
rate, body mass index, ejection fraction, left ventricular diastolic
diameter, left ventricular systolic diameter, left atrial diameter,
right atrial diameter, fractional shortening) only age was det-
ermined to have a prognostic signiﬁcance with TACT (β coef-
ﬁcients¼0.342, p¼0.001). In the multivariate regression analyses,
a non-signiﬁcant association between age and TACT was observed
(β coefﬁcients¼0.163, p¼0.132).
The comparison of TACT obtained by TDI and EPS was tested by
the Bland–Altman method that revealed the compliance and large
limits of agreement (Fig. 2).5. Discussion
Atrial ﬁbrillation is widely recognized as the most common
sustained arrhythmia. The risk of AF development may be deter-
mined by evaluating the patients’ age, sex, underlying heart disease,
other medical illnesses, and echocardiographic ﬁndings. However,
better predictors of AF are needed for early and effective preventive
measures. TACT is a promising parameter for the prediction of AF.
Previous studies have identiﬁed TACT as an important predictor of
AF. Additionally, it is independently associated with AF incidence
[1,2,8]. A recent study also showed that the TACT is an independent
predictor of AF recurrence and can be used to predict the main-
tenance of SR after external electrical CV [9]. In this study, we aimed
to evaluate the validation of the TDI technique for the measurement
of TACT, particularly in healthy individuals.
In this study, the EPS and TDI measurements of TACT were found
to be similar in all age and sex groups 2. Additionally, the EPS-
derived measurements of TACT were positively correlated with the
TDI-derived measurements among the healthy subjects of all age-
and sex-matched groups. These results showed us that the TDI
method might be used accurately and conﬁdently, instead of the
EPS, for the evaluation of TACT in persons without cardiovascular
and systemic diseases. Echocardiographic evaluation with TDI is
currently the most commonly used method for the measurement of
TACT because of the invasive nature and high cost of the EPS pro-
cedure [1,2]. The validation of the measurement of ACT by means of
a non-invasive method such as TDI is very important for the new
trials on atrial ﬁbrillation and supraventricular arrhythmias.
In a similar validation study, Fuenmayor et al. [5] found a cor-
relation between the echocardiography-derived atrial conduction
times and the electrophysiological measured atrial conduction
times in 21 patients with supraventricular tachycardia, in accord
with our trial. However, the measurements by means of echo-
cardiography and EPS in that study were found to be signiﬁcantlys) Group III (Women, 30–40 years) Group IV (Men, 30–40 years) p Value
63.876.4 64.276.5 40.05
33.171.7 32.270.9 40.05
22.474.1 23.674.1 40.05
46.171.8 45.871.1 40.05
30.971.0 30.371.1 40.05
38.171.7 38.371.4 40.05
astolic, LVES¼ left ventricular end-systolic, FS ¼ fractional shortening, Values are
Table 3
Comparison of total atrial and interatrial conduction times (TACT), as measured by TDI and EPS, according to age and sex groups.
20–30 years Total atrial conduction time TACT 30–40 years Total atrial conduction time TACT
Women 66.00 64.00 Women 79.00 76.00
65.00 66.00 66.00 63.00
68.00 68.20 64.00 68.00
72.00 66.80 73.00 77.00
63.00 71.90 78.00 77.00
72.00 66.80 82.00 81.00
60.00 64.20 83.00 83.00
70.00 71.30 86.00 85.00
66.00 66.80 84.00 80.00
70.00 64.90 82.00 78.00
66.00 71.00 88.00 79.00
72.00 72.00 75.00 78.00
63.00 63.00 77.00 74.00
72.00 65.00 64.00 62.00
80.00 84.00 83.00 82.00
70.00 69.00 82.00 75.00
66.00 67.00 86.00 77.00
68.00 69.00 81.00 87.00
72.00 73.00 82.00 88.00
68.00 70.00 82.00 84.00
Mean7SD 68.474.4n 68.674.6n Mean7SD 78.777.4nn 77.977.1nn
Men 72.00 67.00 Men 64.00 57.50
68.00 70.00 67.00 61.20
74.00 71.00 74.00 81.00
74.00 79.40 68.00 73.00
79.00 77.00 75.00 67.00
82.00 84.30 77.00 71.00
68.00 65.00 74.00 82.00
72.00 74.00 71.00 73.00
66.00 68.00 78.00 80.00
68.00 67.00 82.00 81.00
66.00 68.00 86.00 86.00
65.00 66.00 85.00 85.50
68.00 67.00 78.00 77.00
72.00 72.00 83.00 83.00
71.00 70.00 86.00 85.00
67.00 68.00 84.00 80.00
72.00 70.00 88.00 83.00
72.00 71.00 82.00 84.00
76.00 78.00 77.00 79.00
79.00 78.00 71.00 73.00
Mean7SD 71.474.9& 71.575.3& Mean7SD 77.377.3&& 76.977.1&&
All n, nn, & and && demonstrate the absence of statistical signiﬁcance, p40.05.
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cardiographic techniques and subject populations. Namely, we used
the TDI, which is the newer and the most often used technique, and
received the signal from LA lateral wall just over the mitral annulus.
However, Fuenmayor et al. used conventional Doppler echocardio-
graphy and performed the measurement from the beginning of P
wave to the mitral valve A wave. Additionally, we believe that most
important reason for the differences in results is the fact that the
subjects in the present study were without arrhythmia while the
other study population consisted of patients with supraventricular
tachycardia. Another superiority of the present study is the large
study population.
In another similar study, Deniz et al. determine the correlation
of inter- and intraatrial conduction times between the electro-
physiological and tissue Doppler echocardiographic measure-
ments, and evaluated the appropriateness of tissue Doppler
echocardiography for this measurement [10]. The study popula-
tion included patients who underwent electrophysiological studies
for clinical arrhythmias. They found a weak correlation between
the measurement of the interatrial conduction times with the
electrophysiological and tissue Doppler techniques. A mode-
366rate correlation was found in the intraleft atrial conduction
times. They concluded that tissue Doppler echocardiographymight be used for the measurement of interatrial and intra-left
atrial conduction times [10]. The validation of the ACT in the dif-
ferent age and sex groups, is one the most important differences of
our study. Additionally, the present study population was free of
arrhythmia while the other study population consisted of different
types of patients with supraventricular tachycardia. The result of
the present study showed the closed correlation between the
measurements of interatrial conduction times with the electro-
physiological and tissue Doppler techniques just in healthy person
without cardiovascular and systemic diseases. For that reason, we
believed that the generalizations of our study result not be
appropriate for the subject with arrhythmias and systemic
diseases.
In the present study, the TACT measurement scores by EPS and
TDI among women aged 20–30 were statistically and borderline
signiﬁcantly lower than in those aged 30–40. Similarly, men aged
20–30 years had lower scores than those aged 30–40. However,
non-signiﬁcant statistical differences were observed between the
two groups. We believe that this is because of the small sample
size. Similarly, the present study results clearly show decreased
atrial conduction due to aging [11–14]. Kistler et al. showed that
aging is associated with a decrease in the regional conduction,
anatomically determined conduction delay at the crista, and
Fig. 1. TACT values, as measured by TDI and EPS, and their correlations.
Fig. 2. Blan–Altman plot showing the compliance and the large limits of
agreement.
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animal study, Hayashi et al. concluded that heterogeneous atrial
interstitial ﬁbrosis and atrial cell hypertrophy might contribute to
decreased atrial conduction due to aging [12]. The incidence ofatrial ﬁbrillation (AF) increases with age. Anyukhovsky et al. con-
cluded that dispersion of atrial repolarization increases with aging,
creating a substrate for initiation of AF [13]. Additionally, Babaev
et al. conﬁrmed that age-related atrial conduction delay is also
present in healthy subjects [14]. To the best of our knowledge, the
present study is the ﬁrst that has shown decreased atrial con-
duction due to aging by EPS and TDI in the literature.5.1. Limitations of the study
First, the main limitation of our study was its relatively small
group of patients. Since a small sample size results in low statis-
tical power for equivalency testing, negative results may be simply
because of chance. Second, the study had a single-center design.
Future prospective studies at larger multicenter are required to
conﬁrm our results. The third limitation is that we cannot apply
the present study results to the general population, especially to
patients with arrhythmias, cardiovascular and systemic diseases,
because of the broad exclusion criteria. As a methodological point
of TDI and EPS measurements, the surface ECG might be improved
in order to identify the exact onset of P-wave.
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To the best of our knowledge, this is the ﬁrst study that aimed
to demonstrated the validation of TDI and EPS in the measurement
of the TACT among different age and sex groups in healthy subjects
without cardiovascular and systemic diseases. TDI measurements
were found to be similar and strongly correlated with the mea-
surements performed by EPS in the assessment of TACT among
healthy subjects. TDI measurements of TACT are signiﬁcantly
advantageous because of the low cost and non-invasiveness. Thus,
the measurement of TACT via TDI may be used accurately and
conﬁdently instead of the EPS among healthy subjects without
cardiovascular and systemic diseases.Conﬂict of interest
All authors declare no conﬂicts of interest related to this study.References
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